CSIMarket



Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's Income from Cont. Operations Growth by Quarter and Year

Amgen Inc 's Income from Cont. Operations results by quarter and year




AMGN Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,899.00 1,615.00 1,703.00
III Quarter September - 1,884.00 2,021.00 1,968.00
II Quarter June - 464.00 1,803.00 2,179.00
I Quarter March 1,476.00 1,646.00 1,825.00 1,992.00
FY   1,476.00 5,893.00 7,264.00 7,842.00



AMGN Income from Cont. Operations first quarter 2022 Y/Y Growth Comment
Amgen Inc reported fall in Income from Cont. Operations in the first quarter 2022 by -10.33% to $ 1,476.00 millions, from the same quarter in 2021.
The decline in the first quarter 2022 Amgen Inc 's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations growth of 4.18%.

Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 12 other companies have achieved higher Income from Cont. Operations growth. While Amgen Inc ' s Income from Cont. Operations decrease of -10.33% ranks overall at the positon no. 1316 in the first quarter 2022.




AMGN Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 17.59 % -5.17 % -11.67 %
III Quarter September - -6.78 % 2.69 % 5.86 %
II Quarter June - -74.27 % -17.26 % -5.1 %
I Quarter March -10.33 % -9.81 % -8.38 % -13.8 %
FY   - -18.87 % -7.37 % -6.58 %

Financial Statements
Amgen Inc 's first quarter 2022 Income from Cont. Operations $ 1,476.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2021 Income from Cont. Operations $ 1,646.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Income from Cont. Operations Growth >>


AMGN Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 0.8 % -20.09 % -13.47 %
III Quarter September - 306.03 % 12.09 % -9.68 %
II Quarter June - -71.81 % -1.21 % 9.39 %
I Quarter March -22.27 % 1.92 % 7.16 % 3.32 %
FY (Year on Year)   - -18.87 % -7.37 % -6.58 %




Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #13
Healthcare Sector #91
Overall #1316

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
281.2 % 4.18 % -75.8 %
(Dec 31 2018)   (Dec 31 2017)
Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #13
Healthcare Sector #91
Overall #1316
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
281.2 % 4.18 % -75.8 %
(Dec 31 2018)   (Dec 31 2017)

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Amgen Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
7771.43 % 120.15 % -98.6 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2022 Amgen Inc reported fall in Income from Cont. Operations sequentially by -22.27% to $ 1,476.00 millions, from $ 1,899.00 millions achived in the previous quarter.

Some periodic circumstance that normally elevate I. Quarter 2022 results, could not salvage the I. Quarter for the Amgen Inc , Alejandro Ortiz, market veteran said, he voiced some skepticism for the AMGN's outlook and continued that average sequential Income from Cont. Operations growth is at 120.15% for AMGN.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Amgen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 1172.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #74
Overall #1172
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #74
Overall #1172
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
7771.43 % 120.15 % -98.6 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2022 Amgen Inc disclosed fall in Income from Cont. Operations from the forth quarter by -22.27% to $ 1,476.00 millions, from $ 1,899.00 millions released in the previous quarter.

Even seasonal influence which normally fuel I. Quarter 2022 performance, this clearly could not be enough to salvage AMGN's I. Quarter outcome, Alejandro Ortiz, market veteran said.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Amgen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 1172.


Amgen Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ 5,723.00 $ 5,893.00 $ 5,609.00 $ 5,746.00 $ 7,085.00
Y / Y Income from Cont. Operations Growth (TTM) -19.22 % -18.87 % -23.71 % -21.28 % -7.69 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 1368 # 1142 # 1522 # 1361 # 536
Seqeuential Income from Cont. Operations Change (TTM) -2.88 % 5.06 % -2.38 % -18.9 % -2.46 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1316 # 941 # 1632 # 2111 # 675




Cumulative Income from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months Income from Cont. Operations continue to fall, but on the faster rate at -19.22% year on year, at Mar 31 2022 compare to the -18.87% decrease at Dec 31 2021. If the Amgen Inc 's fiscal year would end at Mar 31 2022, annual Income from Cont. Operations would be $5,723 millions.

In the Healthcare sector 95 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 1142 to 1368.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
281.2 %
4.18 %
-75.8 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 96
Overall # 1368

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
324.15 %
18.6 %
-74.37 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 91
S&P 500 # 1316
Cumulative Income from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months Income from Cont. Operations continue to fall, but on the faster rate at -19.22% year on year, at Mar 31 2022 compare to the -18.87% decrease at Dec 31 2021. If the Amgen Inc 's fiscal year would end at Mar 31 2022, annual Income from Cont. Operations would be $5,723 millions.

In the Healthcare sector 95 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 1142 to 1368.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
281.2 %
4.18 %
-75.8 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 96
Overall # 1368

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
324.15 %
18.6 %
-74.37 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 91
S&P 500 # 1316




Other Income from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
AMGN's Income from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for AMGN's Competitors
Income from Cont. Operations Growth for Amgen Inc 's Suppliers
Income from Cont. Operations Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Income from Cont. Operations fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2022
Chemed Corporation-1.88%$ -1.882 millions
Biomx Inc -2.77%$ -2.773 millions
Ironwood Pharmaceuticals inc -2.82%$ -2.818 millions
Corcept Therapeutics Inc-2.85%$ -2.847 millions
Msa Safety Inc-2.89%$ -2.891 millions
Merit Medical Systems Inc-3.77%$ -3.769 millions
Addus Homecare Corporation-4.77%$ -4.767 millions
Idexx Laboratories Inc-5.05%$ -5.054 millions
Hca Healthcare Inc -7.28%$ -7.278 millions
National Research Corporation-7.51%$ -7.506 millions
Amgen Inc -10.33%$ -10.328 millions
Petmed Express Inc-10.95%$ -10.951 millions
Organon and Co -11.90%$ -11.899 millions
Regeneron Pharmaceuticals Inc -12.71%$ -12.706 millions
Intuitive Surgical Inc -15.12%$ -15.119 millions
Apollo Medical Holdings Inc -16.50%$ -16.496 millions
Encompass Health Corporation-17.09%$ -17.093 millions
Molecular Templates Inc -19.30%$ -19.296 millions
Royalty Pharma Plc-19.43%$ -19.434 millions
Natus Medical Inc-20.58%$ -20.576 millions
Fulgent Genetics Inc -23.49%$ -23.486 millions
Quest Diagnostics Inc-23.88%$ -23.878 millions
Fonar Corporation-24.12%$ -24.122 millions
Hologic Inc-26.49%$ -26.488 millions
Integra Lifesciences Holdings Corp-27.52%$ -27.521 millions
Universal Health Services Inc -27.77%$ -27.765 millions
National Healthcare Corp-27.97%$ -27.966 millions
Incyte Corp-29.03%$ -29.033 millions
Davita Inc -29.44%$ -29.439 millions
Reynolds Consumer Products Inc -29.73%$ -29.730 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DSWR's Profile

Stock Price

DSWR's Financials

Business Description

Fundamentals

Charts & Quotes

DSWR's News

Suppliers

DSWR's Competitors

Customers & Markets

Economic Indicators

DSWR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071